Medication Reviews and Clinical Outcomes in Persons with Dementia: A Scoping Review

• Main Authors: Rishabh Sharma (Author), Neil Mahajan (Author), Sarah Abu Fadaleh (Author), Hawa Patel (Author), Jessica Ivo (Author), Sadaf Faisal (Author), Feng Chang (Author), Linda Lee (Author), Tejal Patel (Author)
• Format: Book
• Published: MDPI AG, 2023-10-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.
• Notes: 10.3390/pharmacy11050168; 2226-4787
• Keywords: older adults; dementia; medication review; drug-related problems; Pharmacy and materia medica; RS1-441
• Source: Pharmacy, Vol 11, Iss 5, p 168 (2023)

Persons diagnosed with dementia are often faced with challenges related to polypharmacy and inappropriate medication use and could benefit from regular medication reviews. However, the benefit of such reviews has not been examined in this population. Therefore, the current scoping review was designed to identify the gaps in the current knowledge regarding the impact of medication reviews on the clinical outcomes in older adults with dementia. Relevant studies were identified by searching three databases (Ovid MEDLINE, Ovid EMBASE, and Scopus) from inception to January 2022 with a combination of keywords and medical subject headings. After the removal of duplicates and ineligible articles, 22 publications of the initial 8346 were included in this review. A total of 57 outcomes were identified, including those pertaining to the evaluation of medication use (n = 17), drug-related interventions (n = 11), drug-related problems (n = 10), dementia-related behavioral symptoms (n = 8), cost-effectiveness (n = 2), drug-related hospital admissions (n = 1), as well as outcomes classified as other (n = 7). Gaps identified through this scoping review included the paucity of studies measuring the impact of medication reviews on the medication management capacity and medication adherence, quality of life, and mortality.